Loading...
XSHE
002258
Market cap1.59bUSD
Jul 10, Last price  
13.43CNY
1D
-2.40%
1Q
-10.41%
Jan 2017
51.24%
IPO
108.54%
Name

Lier Chemical Co Ltd

Chart & Performance

D1W1MN
XSHE:002258 chart
P/E
22.45
P/S
1.19
EPS
0.60
Div Yield, %
2.98%
Shrs. gr., 5y
1.03%
Rev. gr., 5y
12.64%
Revenues
9.01b
+23.21%
262,803,447304,019,433403,999,580394,209,552445,312,819936,008,3871,278,092,6271,440,423,0461,317,389,5511,489,071,4841,982,302,5983,083,547,8914,027,069,3394,163,842,1234,968,747,8236,494,251,25610,136,144,2227,850,607,4957,310,881,6829,007,754,100
Net income
479m
+122.33%
99,440,361107,022,37587,675,709101,153,25871,738,07569,621,90887,621,136104,088,60892,412,065138,453,584208,347,322401,967,207577,810,922311,142,629612,208,8771,072,386,6411,812,519,450603,888,247215,336,807478,767,100
CFO
1.30b
+314.93%
53,541,25489,843,36931,800,197127,541,20482,482,17540,146,709103,306,903108,899,371140,335,346156,796,906184,861,778362,985,774348,038,821589,723,367899,001,3641,317,229,8942,596,557,328938,573,493312,504,4121,296,668,520
Dividend
Sep 23, 20250.2 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1993 and based in Mianyang, China, Lier Chemical Co.,LTD. functions as a comprehensive entity focused on the research, development, manufacturing, and worldwide distribution of agrochemical products. The company's diverse product line encompasses a selection of low-toxicity and low-residue pesticides, including prominent examples such as chloropyridines and organophosphates. Its extensive offerings for crop protection also feature numerous herbicides, specifically pinoxaden, glufosinate-ammonium, diquat, flumioxazin, clodinafop-propargyl, clopyralid acid, picloram, fluroxypyr-meptyl, triclopyr, diuron, bensulfuron-methyl, linuron, pyrazosulfuron-ethyl, nicosulfuron, flufenacet, mefenacet, and quinclorac. Additionally, Lier Chemical provides fungicides like azoxystrobin, epoxiconazole, iprodione, and difenoconazole, alongside insecticides such as chlorpyrifos and pyriproxyfen. Beyond its agricultural chemical focus, the company produces active pharmaceutical ingredients (APIs) and their respective formulations. A substantial part of its business involves the synthesis of a broad spectrum of chemical intermediates, most notably pyridine derivatives including 2-chloropyridine, 2,3-dichloropyridine, 2,5-dichloropyridine, 2,6-dichloropyridine, 2,3,4-trichloropyridine, 2,3,5-trichloropyridine, 2,3,6-trichloropyridine, nitrapyrin, pentafluoropyridine, 2,3,5,6-tetrachloro-4-methylsulfonylpyridine, 6-chloropyridine-2-carbonitrile, 3,6-difluoropyridine-2-carboxylic acid, 2,2'-bipyridine, 2-chloro-4'-fluoroacetophenone, 2-chloro-2',4'-difluoroacetophenone, and 2-fluoro-3-nitrobenzoic acid. Other specialized intermediates manufactured include (E)-4-(dimethylamino)but-2-enoic acid hydrochloride, 4,4'-dichloro-[3,3']bipyridinyl, clopyralid-methyl, methyl 3,4,6-trichloropicolinate, 2,4,5-trichloropyridine, 7-fluoro-6-nitro-4-hydroxyquinazoline, N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine, 4-bromocrotonic acid, 4-N-(3-chloro-4-fluorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazoline-4,6-diamine, 2-amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide, and 5-chloro-8-hydroxyquinoline.
IPO date
Jul 08, 2008
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT